SEI Investments’s Roivant Sciences ROIV Stock Holding History

SEI Investments’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.07M	Buy	143,215 +22,889	+19%	+$676K	﹤0.01%	1504
2026 Q1	$3.33M	Buy	120,326 +33,508	+39%	+$861K	﹤0.01%	1759
2025 Q4	$1.88M	Buy	86,818 +39,254	+83%	+$774K	﹤0.01%	1887
2025 Q3	$720K	Buy	47,564 +45	+0.1%	+$557	﹤0.01%	2091
2025 Q2	$536K	Buy	47,519 +13,734	+41%	+$149K	﹤0.01%	2153
2025 Q1	$341K	Buy	33,785 +11,596	+52%	+$125K	﹤0.01%	2287
2024 Q4	$262K	Hold	22,189	–	–	﹤0.01%	2401
2024 Q3	$256K	Buy	22,189 +38	+0.2%	+$433	﹤0.01%	2406
2024 Q2	$234K	Buy	22,151 +8,667	+64%	+$95K	﹤0.01%	2417
2024 Q1	$142K	Sell	13,484 -5,385	-29%	-$58.1K	﹤0.01%	2471
2023 Q4	$212K	Buy	18,869 +5,715	+43%	+$55.7K	﹤0.01%	2426
2023 Q3	$154K	Buy	+13,154	New	+$149K	﹤0.01%	2464

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

SEI Investments's ROIV Position: Q2 2026 in Review

SEI Investments increased its Roivant Sciences (ROIV) stake by 19% in Q2 2026, buying an estimated $676K and bringing the position to 143,215 shares worth $5.07M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.

SEI Investments first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

SEI Investments held 143,215 shares of Roivant Sciences worth $5.07M as of Q2 2026.
SEI Investments bought 22,889 Roivant Sciences shares in Q2 2026, an estimated $676K.
Roivant Sciences made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1504 holding.
SEI Investments first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.